Vimarsana
Biggest News Aggregation in the World

Page 11 - Breakthrough Designation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Designation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Designation Today - Breaking & Trending Today

CASI PHARMACEUTICALS' PARTNER JUVENTAS ANNOUNCES NEW DRUG APPLICATION FOR CNCT19 ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION - Vimarsana News

CASI PHARMACEUTICALS' PARTNER JUVENTAS ANNOUNCES NEW DRUG APPLICATION FOR CNCT19 ACCEPTED BY CHINA NATIONAL MEDICAL PRODUCTS ADMINISTRATION

/PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on developing and commercializing innovative therapeutics...

A New Study in the Proceedings of the National Academy of Sciences (PNAS) Demonstrates the Ability o - Vimarsana News

A New Study in the Proceedings of the National Academy of Sciences (PNAS) Demonstrates the Ability o

AltPep Corporation is developing a unique platform to target disease many years before symptomsSEATTLE--(BUSINESS WIRE)--AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, today announced that this week the Proceedings of...

Datar Cancer Genetics Designates Dr. Massimo Cristofanilli as Chairman of the Board of Scientific Advisors - Vimarsana News

Datar Cancer Genetics Designates Dr. Massimo Cristofanilli as Chairman of the Board of Scientific Advisors

Datar Cancer Genetics, a world leader in non-invasive cancer screening and diagnostics, today announced that it had designated Dr. Massimo Cristofanilli, a

Novel Treatment of Opioid Use Disorder Receives Grant for Continued Research - Vimarsana News

Novel Treatment of Opioid Use Disorder Receives Grant for Continued Research

/PRNewswire/ -- A novel approach to the treatment of opioid use disorder called Dual-Brain Psychology (DBP) has received a Phase II grant for continued...

Week In Review: VectorBuilder Raises $57 Million For Gene Therapy Delivery CDMO - Vimarsana News

Week In Review: VectorBuilder Raises $57 Million For Gene Therapy Delivery CDMO

Chicago-based VectorBuilder, a gene therapy delivery CDMO, raised $57 million in a Series C round from China investors.